Literature DB >> 10945661

Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis.

F Squitieri1, A Berardelli, E Nargi, B Castellotti, C Mariotti, M Cannella, M L Lavitrano, U de Grazia, C Gellera, S Ruggieri.   

Abstract

Huntington's disease (HD) is notably difficult to diagnose in the early stages. One reason is that the early clinical manifestations of HD vary widely and sometimes have an atypical onset. In this paper we primarily sought information on affected patients who initially presented with movement disorders other than chorea. We also investigated atypical motor presentations in relation to triplet CAG expansions. After reviewing the clinical records of two neurological centres, we identified patients with a final, documented diagnosis of HD and selected for study 205 patients according to their onset of motor manifestations. CAG repeats were analysed. Of the 205 patients studied, 15 had atypical motor symptoms at onset. In this group we identified three types of initial clinical manifestations other than chorea: parkinsonism, ataxia and dystonia. We conclude that HD patients may have different motor manifestations at the initiation of the illness. Patients with atypical movement disorders in the early stages have larger CAG expansions and an earlier age at onset than HD patients with typical onset chorea.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945661     DOI: 10.1034/j.1399-0004.2000.580108.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  21 in total

Review 1.  Molecular medicine: predicting and preventing Huntington's disease.

Authors:  Ferdinando Squitieri; Milena Cannella; Luigi Frati
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

2.  Huntington's Disease Revealed by Familial Cervical Dystonia.

Authors:  Daniela Andriuta; Mélissa Tir; Olivier Godefroy; Pierre Krystkowiak
Journal:  Mov Disord Clin Pract       Date:  2016-01-18

3.  Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.

Authors:  Jason Miller; Montserrat Arrasate; Benjamin A Shaby; Siddhartha Mitra; Eliezer Masliah; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

Review 4.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

5.  Huntington's disease masquerading as spinocerebellar ataxia.

Authors:  Sergio Alejandro Rodríguez-Quiroga; Dolores Gonzalez-Morón; Nelida Garretto; Marcelo Andres Kauffman
Journal:  BMJ Case Rep       Date:  2013-07-12

Review 6.  Development of Research on Huntington Disease in China.

Authors:  Hong-Lei Li; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

7.  Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Authors:  Ferdinando Squitieri; Sara Orobello; Milena Cannella; Tiziana Martino; Pantaleo Romanelli; Giampiero Giovacchini; Luigi Frati; Luigi Mansi; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

Review 8.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

9.  Comment on Clinical Profile of Genetically Proven Huntington's Disease Patients From Eastern India.

Authors:  Gustavo L Franklin; Carlos Henrique Camargo; Alex T Meira; Hélio A G Teive
Journal:  Ann Indian Acad Neurol       Date:  2020-06-24       Impact factor: 1.383

Review 10.  [Neuropsychiatric aspects of Huntington chorea. Presentation of 2 cases and review of the literature].

Authors:  H Tost; A Schmitt; S Brassen; C S Wendt; D F Braus
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.